Outsourced Pharma Capacity Update Videos - Large Molecule
-
Northway Biotech Capacity Update January 2025: Large Molecule Development
1/28/2025
Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.
-
Mabion Capacity Update January 2025: Large Molecule Development
1/28/2025
Go on a virtual tour of our GMP-certified facility, where we uphold our expanded capabilities for large molecule development to the highest standards for clinical and commercial manufacturing.
-
KBI Biopharma Capacity Update January 2025: Large Molecule Development
1/28/2025
Follow along as Derek Ryan, Sr. Director of Analytical Development, showcases our high-throughput technology and digital tools for process understanding and optimizing decision-making.
-
Cytovance Biologics Capacity Update January 2025: Large Molecule Development
1/28/2025
Join Rose Rhomberg, Senior Business Development Director, as she showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity.
-
Catalent Capacity Update January 2025: Large Molecule Development
1/28/2025
Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.
-
Northway Biotech Capacity Update October 2024: Large Molecule Drug Substance
10/22/2024
We have the capabilities, competitive advantages, and capacity to onboard new projects across two facilities: Waltham, MA, operational since 2020, and Vilnius, Lithuania, established in 2004.
-
Cytovance Biologics Capacity Update October 2024: Large Molecule Drug Substance
10/22/2024
Senior Business Development Director Rose Rhomberg presents an in-depth look at Cytovance’s capabilities and highlights the available capacity designed to accelerate your goals.
-
Novartis Contract Manufacturing Capacity Update October 2024: Large Molecule Drug Substance
10/22/2024
Gain valuable insights into our mammalian development services, manufacturing solutions, upcoming capacity availability, as well as updates on expansion timelines for external clients.
-
Curia Capacity Update October 2024: Large Molecule Drug Substance
10/22/2024
We offer adaptable, comprehensive solutions to advance your program seamlessly from IND-enabling studies through to late-stage commercial production.
-
Pfizer CentreOne Capacity Update October 2024: Large Molecule Drug Substance
10/22/2024
See how our specialized manufacturing site in Sanford, NC — backed by over 35 years of expertise in mAb production — can expedite the delivery of your groundbreaking therapies to patients.